AusBiotech And BioNSW Sign MOU To Deepen Collaboration

AusBiotech, Australia's leading national industry body representing more than 3,000 life sciences members, has formalised a new partnership with BioNSW, a rapidly growing not-for-profit organisation dedicated to harnessing the full potential of the New South Wales Life Sciences sector. The signing of this Memorandum of Understanding (MOU) represents a significant step forward in promoting a connected and thriving biotechnology ecosystem across NSW and beyond.

The partnership underscores a shared commitment to catalysing innovation, investment, and skills development across the sector. Together, AusBiotech and BioNSW will work to amplify the strengths of NSW's biotechnology industry, accelerating cross-sector collaboration and promoting growth.

Rebekah Cassidy, CEO of AusBiotech, stated:

"I couldn't be more pleased to sign this MOU with BioNSW. It reflects our shared commitment to growing Australia's life sciences capabilities and reinforces AusBiotech's commitment to fostering a connected biotechnology sector. I look forward to working with the BioNSW team to showcase the state's strengths and offerings."

"My consistent message has been that, as the leading national advocate, we have a responsibility to collaborate and deepen our relationships with our partners in each of the states, including New South Wales. Through our own thriving membership, we know that NSW's biotech and medtech community is exciting and strong. Coordinating locally and nationally to foster joint advocacy is a critical enabler for the future of our sector. Unifying the sector's voice must be one of our most critical, shared priorities."

Brad Walsh, Acting Chair and Co-Founder of BioNSW, said:

"As Acting Chair and Co-Founder of BioNSW, I'm delighted to see the formalisation of this partnership with AusBiotech, a key step forward in strengthening the biotechnology ecosystem across New South Wales and beyond.

"The NSW LifeSciences Sector is significant in size and importance with the largest number of Biotech companies amongst the states – with the sector having doubled in size over the last 7 years.

"BioNSW is committed to amplifying the voice of our local Life Sciences organisations across all regions of the State, ensuring that the unique needs and opportunities of NSW's Life Sciences community are well-represented at every level. This partnership with the national body AusBiotech underscores our role as a vital advocate, connecting businesses, fostering innovation, and promoting growth.

"By working together with AusBiotech, BioNSW is excited to help drive the development of a thriving, connected biotechnology sector in NSW, positioning the state as a leader in the global bio-economy."

About AusBiotech

AusBiotech is Australia's leading national and global advocate for life sciences, working to help its more than 3000 members thrive by shaping policy, creating connections, and fostering knowledge sharing. With an unrivalled national convening power, AusBiotech supports its members' growth by building an Australian life sciences ecosystem that leads in development and commercialisation, creating high-quality, innovative life sciences companies.  

About BioNSW

BioNSW is an ambitious State-Focused, Industry-led organisation dedicated to harnessing the full potential of the NSW Life Sciences sector - catalysing innovation as well as + investment, skills and jobs in the NSW Life Sciences sector and facilitating economic growth, prosperity and a healthier NSW community.

Established in 2023 as a Not-for-Profit Organisation, BioNSW is led by an experienced Cross-Sector Board and supported by a group of Expert Committees covering areas ranging from Biotech, MedTech, Digital Health through to Manufacturing, Commercialisation and Investment.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.